Pazopanib efficacy in recurrent central nervous system hemangiopericytomas
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Neuro-Oncology"
DOI: 10.1007/s11060-018-2870-0
Abstract: IntroductionThere is currently no treatment for solitary fibrous tumors/hemangiopericytomas (SFT/H) of the central nervous system recurring after multiple surgeries and radiotherapies. The NAB2-STAT6 gene fusion is the hallmark of these tumors, and upregulates Early Growth… read more here.
Keywords: nervous system; central nervous; pazopanib efficacy; sft ... See more keywords